Daiwa Securities Group
DYN icon

Daiwa Securities Group’s Dyne Therapeutics DYN Stock Holding History

Daiwa Securities Group’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-424
Closed -$8K – 1259
2025
Q4 		$8K Buy
424
+53
+14% +$1K ﹤0.01% 1200
2025
Q3 		$5K Hold
371
– – ﹤0.01% 1200
2025
Q2 		$4K Hold
371
– – ﹤0.01% 1170
2025
Q1 		$4K Hold
371
– – ﹤0.01% 1144
2024
Q4 		$9K Hold
371
– – ﹤0.01% 1124
2024
Q3 		$13K Hold
371
– – ﹤0.01% 1117
2024
Q2 		$13K Buy
371
+71
+24% +$2.06K ﹤0.01% 1153
2024
Q1 		$9K Buy
300
+90
+43% +$2.04K ﹤0.01% 1171
2023
Q4 		$3K Hold
210
– – ﹤0.01% 1242
2023
Q3 		$2K Hold
210
– – ﹤0.01% 1215
2023
Q2 		$2K Hold
210
– – ﹤0.01% 1228
2023
Q1 		$2K Hold
210
– – ﹤0.01% 1210
2022
Q4 		$2K Buy
210
+60
+40% +$694 ﹤0.01% 1219
2022
Q3 		$2K Hold
150
– – ﹤0.01% 1224
2022
Q2 		$1K Hold
150
– – ﹤0.01% 1284
2022
Q1 		$1K Hold
150
– – ﹤0.01% 1304
2021
Q4 		$2K Buy
+150
New +$2.11K ﹤0.01% 1279

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Daiwa Securities Group's DYN Position: Q1 2026 in Review

Daiwa Securities Group sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 424 shares — an estimated $8K sold.

Daiwa Securities Group first reported a position in DYN in Q4 2021 and held it in 17 quarters. The position peaked at $13K in Q3 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Daiwa Securities Group reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 424 Dyne Therapeutics shares in Q1 2026, an estimated $8K.
  • Daiwa Securities Group first reported a position in Dyne Therapeutics in Q4 2021 and held it in 17 quarters.
  • Daiwa Securities Group's Dyne Therapeutics position peaked at $13K in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.